3 results match your criteria: "Albany Medical Center College[Affiliation]"
Respir Care
February 2022
Division of Pulmonary and Critical Care Medicine, Albany Medical Center College, Albany, New York.
Background: Bronchoscopy is an aerosol-generating procedure and routine use for patients with coronavirus disease 2019 (COVID-19) has been discouraged. The purpose of this review was to discuss the indications, clinical utility, and risks associated with bronchoscopy in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
Methods: A literature search was performed by using appropriate key terms to identify all relevant articles from medical literature databases up to August 1, 2021.
Am J Med Sci
December 2020
Division of Pulmonary and Critical Care Medicine, Albany Medical Center College, Albany, New York.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the coronavirus disease -19 (COVID-19). Since December 2019, SARS-CoV-2 has infected millions of people worldwide, leaving hundreds of thousands dead. Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial medications that have been found to have in vitro efficacy against SARS-CoV-2.
View Article and Find Full Text PDFAm J Med Sci
July 2020
Division of Critical Care Nursing, Albany Medical Center College, Albany, New York. Electronic address: